Biodexa Pharmaceuticals PLC ADR (BDRX)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 13
0
0%
$
1.69M Market Cap
- P/E Ratio
- Div Yield
31,400 Volume
- Eps
$ 2.13
Previous Close Investors:
Want to track BDRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biodexa Pharmaceuticals PLC ADR (BDRX) Statistics
Valuation metrics
Market Cap 1.69M
Enterprise value -7.28M
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.84
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 31.19K
Average volume (90 days) 647.09K
Price summary
52-Week low 2.02
52-Week high 59.4
Beta -
50-Day moving average 2.95
200-Day moving average 5.67
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 6 Apr 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.35%
Return on equity -0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -70.5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 94.31
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 2.03%
Book value per share (mrq) 126.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
